InsidersTradesSigma
Explore the complete record of transactions filed by Perros Manoussos, Chairman & CEO. Officer active across 1 companies, notably Entasis Therapeutics Holdings Inc.. Aggregated, 6 disclosures have been recorded. The latest transaction was filed on 18 January 2022 — Attribution. Regulator: SEC (Form 4). The full history is openly available.
6 of 6 declarations
Manoussos Perros is the Chief Executive Officer of Entasis Therapeutics Holdings Inc. He leads the company's operations, focused on developing innovative treatments. His leadership is crucial to the company's mission in the pharmaceutical sector.